...
search icon
srdx-img

SurModics Inc, Common Stock

SRDX

NSQ

$34.1

-$0.06

(-0.18%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$488.35M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
100.24K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.20
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$25.17 L
$42.44 H
$34.1

About SurModics Inc, Common Stock

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameSRDXSectorS&P500
1-Week Return0.15%-0.03%1.53%
1-Month Return-4.08%4.56%4.75%
3-Month Return-10.48%1.29%2.77%
6-Month Return-13.25%-3.54%12.18%
1-Year Return3.24%1.59%22.34%
3-Year Return-19.44%13.55%38.91%
5-Year Return-13.39%40.85%80.7%
10-Year Return44.86%105.52%190.95%

Financials

Sep '20Sep '21Sep '22Sep '23Sep '245YR TREND
Total Revenue94.86M105.14M99.95M132.58M126.08M[{"date":"2020-09-30","value":71.55,"profit":true},{"date":"2021-09-30","value":79.3,"profit":true},{"date":"2022-09-30","value":75.39,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2024-09-30","value":95.09,"profit":true}]
Cost of Revenue65.50M63.91M70.95M71.56M33.03M[{"date":"2020-09-30","value":91.54,"profit":true},{"date":"2021-09-30","value":89.31,"profit":true},{"date":"2022-09-30","value":99.15,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2024-09-30","value":46.15,"profit":true}]
Gross Profit29.36M41.23M29.00M61.02M93.05M[{"date":"2020-09-30","value":31.55,"profit":true},{"date":"2021-09-30","value":44.3,"profit":true},{"date":"2022-09-30","value":31.17,"profit":true},{"date":"2023-09-30","value":65.58,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Gross Margin30.95%39.21%29.01%46.03%73.81%[{"date":"2020-09-30","value":41.93,"profit":true},{"date":"2021-09-30","value":53.13,"profit":true},{"date":"2022-09-30","value":39.31,"profit":true},{"date":"2023-09-30","value":62.36,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Operating Expenses30.61M33.47M51.10M55.42M98.70M[{"date":"2020-09-30","value":31.01,"profit":true},{"date":"2021-09-30","value":33.91,"profit":true},{"date":"2022-09-30","value":51.77,"profit":true},{"date":"2023-09-30","value":56.15,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Operating Income(1.25M)6.70M(22.10M)5.15M(5.64M)[{"date":"2020-09-30","value":-18.66,"profit":false},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-329.66,"profit":false},{"date":"2023-09-30","value":76.83,"profit":true},{"date":"2024-09-30","value":-84.22,"profit":false}]
Total Non-Operating Income/Expense(336.00K)(667.00K)(994.00K)(6.15M)(5.40M)[{"date":"2020-09-30","value":-33600000,"profit":false},{"date":"2021-09-30","value":-66700000,"profit":false},{"date":"2022-09-30","value":-99400000,"profit":false},{"date":"2023-09-30","value":-615200000,"profit":false},{"date":"2024-09-30","value":-540100000,"profit":false}]
Pre-Tax Income(1.45M)6.35M(22.49M)2.49M(7.51M)[{"date":"2020-09-30","value":-22.91,"profit":false},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-354.44,"profit":false},{"date":"2023-09-30","value":39.19,"profit":true},{"date":"2024-09-30","value":-118.28,"profit":false}]
Income Taxes(2.58M)2.11M4.78M4.02M4.04M[{"date":"2020-09-30","value":-53.9,"profit":false},{"date":"2021-09-30","value":44.11,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":84.15,"profit":true},{"date":"2024-09-30","value":84.42,"profit":true}]
Income After Taxes1.12M4.24M(27.27M)(1.54M)(11.54M)[{"date":"2020-09-30","value":26.5,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-643.71,"profit":false},{"date":"2023-09-30","value":-36.25,"profit":false},{"date":"2024-09-30","value":-272.41,"profit":false}]
Income From Continuous Operations1.12M4.24M(27.27M)(1.54M)(11.54M)[{"date":"2020-09-30","value":26.5,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-643.71,"profit":false},{"date":"2023-09-30","value":-36.25,"profit":false},{"date":"2024-09-30","value":-272.41,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Net Income1.12M4.24M(27.27M)(1.54M)(11.54M)[{"date":"2020-09-30","value":26.5,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-643.71,"profit":false},{"date":"2023-09-30","value":-36.25,"profit":false},{"date":"2024-09-30","value":-272.41,"profit":false}]
EPS (Diluted)0.120.37(0.95)0.15(0.39)[{"date":"2020-09-30","value":32.43,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-256.76,"profit":false},{"date":"2023-09-30","value":40.54,"profit":true},{"date":"2024-09-30","value":-105.41,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SRDX
Cash Ratio 2.29
Current Ratio 5.45
Quick Ratio 4.29

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SRDX
ROA (LTM) -0.66%
ROE (LTM) -12.32%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SRDX
Debt Ratio Lower is generally better. Negative is bad. 0.32
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.68

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SRDX
Trailing PE NM
Forward PE 163.93
P/S (TTM) 3.89
P/B 4.37
Price/FCF NM
EV/R 3.92
EV/Ebitda 218.91
PEG 3.90

FAQs

What is SurModics Inc share price today?

SurModics Inc (SRDX) share price today is $34.1

Can Indians buy SurModics Inc shares?

Yes, Indians can buy shares of SurModics Inc (SRDX) on Vested. To buy SurModics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SRDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of SurModics Inc be purchased?

Yes, you can purchase fractional shares of SurModics Inc (SRDX) via the Vested app. You can start investing in SurModics Inc (SRDX) with a minimum investment of $1.

How to invest in SurModics Inc shares from India?

You can invest in shares of SurModics Inc (SRDX) via Vested in three simple steps:

  • Click on Sign Up or Invest in SRDX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in SurModics Inc shares
What is SurModics Inc 52-week high and low stock price?

The 52-week high price of SurModics Inc (SRDX) is $42.44. The 52-week low price of SurModics Inc (SRDX) is $25.17.

What is SurModics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of SurModics Inc (SRDX) is 4.37

What is the Market Cap of SurModics Inc?

The market capitalization of SurModics Inc (SRDX) is $488.35M

What is SurModics Inc’s stock symbol?

The stock symbol (or ticker) of SurModics Inc is SRDX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top